# News Collection: AI Drug Design

- [20250417 Earendil Labs (Helixon) License Agreement with Sanofi for Bispecific Antibodies](https://www.biospace.com/press-releases/earendil-labs-announces-worldwide-exclusive-license-agreement-with-sanofi-for-next-generation-bispecific-antibodies-for-autoimmune-and-inflammatory-bowel-diseases)


